SEC Info - Evolent Health, Inc. - ‘8-K’ for 2/22/24

SEC Info℠

Home

Help

Please Sign In

Evolent Health, Inc. – ‘8-K’ for 2/22/24

On: Thursday, 2/22/24, at 4:18pm ET · For: 2/22/24 · Accession #: 1628908-24-15 · File #: 1-37415

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/22/24  Evolent Health, Inc.              8-K:2,9     2/22/24   12:716K

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         02.21.2024 8-K                                      HTML     30K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    456K 
 7: R1          Cover Page Cover Page                               HTML     47K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
12: XML         XBRL Instance -- evh-20240222_htm                    XML     14K 
 8: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 4: EX-101.DEF  XBRL Definitions -- evh-20240222_def                 XML     39K 
 5: EX-101.LAB  XBRL Labels -- evh-20240222_lab                      XML     80K 
 6: EX-101.PRE  XBRL Presentations -- evh-20240222_pre               XML     39K 
 3: EX-101.SCH  XBRL Schema -- evh-20240222                          XSD     11K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               13±    20K 
11: ZIP         XBRL Zipped Folder -- 0001628908-24-000015-xbrl      Zip     56K

‘8-K’ — 02.21.2024 8-K

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX:

evh-20240222

i 0001628908 i false00016289082024-02-222024-02-22


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

_________________________

FORM i 8-K

_________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

i February 22, 2024

Date of Report (Date of earliest event reported)

i Evolent Health, Inc.

(Exact name of registrant as specified in its charter)

_________________________

i Delaware

i 001-37415

i 32-0454912

(State or other jurisdiction of
incorporation or organization)

Commission File Number:

(I.R.S. Employer
Identification No.)

i 1812 N. Moore Street

i Suite 1705

i Arlington

i Virginia

i 22209

(Address of principal executive offices)(zip code)

( i 571) i 389-6000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report.)

_________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Class A Common Stock of Evolent Health, Inc., par value $0.01 per share	i EVH	i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition

On February 22, 2024, Evolent Health, Inc. (the "Company") issued a press release announcing its financial results for the quarter and year ended December 31, 2023, a copy of which is furnished herewith as Exhibit 99.1.

The information, including Exhibit 99.1 hereto, furnished under this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject the Company or any other person to liability under that Section, to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act of 1933, as amended (the “Securities Act”), except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.


Exhibit No.						Description
99.1						Press Release of Evolent Health, Inc. dated February 22, 2024.
104						The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


EVOLENT HEALTH, INC.

By:			/s/ *Jonathan D. Weinberg*
Name:			Jonathan D. Weinberg
Title:			General Counsel and Secretary

Date: February 22, 2024

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on / For Period end:	2/22/24	None on these Dates
	12/31/23
		List all Filings

↑Top

Filing Submission 0001628908-24-000015 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Evolent Health, Inc. – ‘8-K’ for 2/22/24

On: Thursday, 2/22/24, at 4:18pm ET · For: 2/22/24 · Accession #: 1628908-24-15 · File #: 1-37415

Previous ‘8-K’: ‘8-K’ on 2/14/24 for 2/12/24 · Latest ‘8-K’: This Filing

Current Report — Form 8-KFiling Table of Contents

‘8-K’ — 02.21.2024 8-K

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Current Report — Form 8-K

Filing Table of Contents